Last reviewed · How we verify
Isoniazid with HUEXC030 and RZE — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Isoniazid with HUEXC030 and RZE (Isoniazid with HUEXC030 and RZE) — Orient Pharma Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Isoniazid with HUEXC030 and RZE TARGET | Isoniazid with HUEXC030 and RZE | Orient Pharma Co., Ltd. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Isoniazid with HUEXC030 and RZE CI watch — RSS
- Isoniazid with HUEXC030 and RZE CI watch — Atom
- Isoniazid with HUEXC030 and RZE CI watch — JSON
- Isoniazid with HUEXC030 and RZE alone — RSS
Cite this brief
Drug Landscape (2026). Isoniazid with HUEXC030 and RZE — Competitive Intelligence Brief. https://druglandscape.com/ci/isoniazid-with-huexc030-and-rze. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab